Linc

Linc Rule of 40

The Rule of 40 of Linc (LINC.ST) as of Nov 20, 2026 is 76,409.47 %. In the previous year, Rule of 40 was 10.64 M % — a change of -99.28% (lower).

Rule of 40

76,409.47 %

YoY

-99.28%

Last updated:

Rule of 40 of Linc is 2025 76,409.47 % . Rule of 40 of Linc was 2024 10.64 M % . It decreases by -99.28% lower compared to the previous year.

The Linc Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2019
12,979.76 SEK
Jan 1, 2020
73,921.58 SEK
Jan 1, 2021
-681.97 SEK
Jan 1, 2022
-37,934.98 SEK
Jan 1, 2023
17,825.15 SEK
Jan 1, 2024
10.64 M SEK
Jan 1, 2025
76,409.47 SEK
The Linc Rule of 40 history
YEARRule of 40YoY
76,409.47 %-99.28%
10.64 M %+59,599.13%
17,825.15 %-146.99%
-37,934.98 %+5,462.55%
-681.97 %-100.92%
73,921.58 %+469.51%
12,979.76 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Rule of 40 of Linc is 76,409.47 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Linc since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Linc

All Key Metrics — Linc